Last update 25 Mar 2025

RS-130830

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
CTS-1027, RO-1130830
Target
Action
inhibitors
Mechanism
MMPs inhibitors(Matrix metalloproteinase inhibitors)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC19H20ClNO6S
InChIKeyROSNVSQTEGHUKU-UHFFFAOYSA-N
CAS Registry193022-04-7

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis CPhase 2
United States
01 Jun 2009
Hepatitis CPhase 2
Puerto Rico
01 Jun 2009
Hepatitis C, ChronicPhase 2
United States
01 Dec 2007
ArthritisPhase 2--
ArthritisPhase 2--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
114
CTS-1027+ribavirin+pegylated interferon
(CTS-1027 60 mg + Ribavirin + Peglyated Interferon)
rnvybdxfjg(ikatpfqcxl) = jrpudkmtdg fpibjloosv (qfmzibkpzi, yailotoitb - mnujwqknre)
-
30 May 2012
Placebo+CTS-1027+ribavirin+pegylated interferon
(CTS-1027 30 mg + Ribavirin + Pegylated Interferon)
rnvybdxfjg(ikatpfqcxl) = nlpumsvvza fpibjloosv (qfmzibkpzi, jmlxbewrfw - xfulgrsocu)
Phase 2
67
Pegylated Interferon+CTS-1027+Ribavirin
snunlxwekt(rygggsfqkq) = vxpvtdhptm zhcwrfeviw (ugayezwdse, jgdrutgjkn - htdqzeubre)
-
10 Apr 2012
Phase 2
70
(CTS-1027 + Ribavirin)
dvpwtxvidd(wpdgwcdbgs) = yavsrpfbjj uvnpyrwhgb (qlbnrcpebg, 0.50)
-
27 Mar 2012
Placebo for ribavirin+CTS-1027
(CTS-1027 + Placebo)
dvpwtxvidd(wpdgwcdbgs) = ekjqyuyvef uvnpyrwhgb (qlbnrcpebg, 0.76)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free